Analysis of glutathione: Implication in redox and detoxification

Clinica Chimica Acta

Volumn 333, Issue 1-2, 2003, Pages 19-39

  Pastore, Anna ^a,b   Federici, Giorgio ^a   Bertini, Enrico ^a   Piemonte, Fiorella ^a  

^a Laboratory of Biochemistry   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Detoxification; Oxidative stress; Oxidised glutathione; Protein bound glutathione; Reduced glutathione

Indexed keywords

GLUTATHIONE;

AGING; AMINO ACID ANALYSIS; ANALYTIC METHOD; AUTOMATION; BIOCHEMISTRY; BIOLUMINOMETRY; BLOOD ANALYSIS; CAPILLARY ELECTROPHORESIS; CLINICAL CHEMISTRY; COST; DERIVATIZATION; DETOXIFICATION; DISEASE ASSOCIATION; ELECTROCHEMICAL DETECTION; FLUOROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE SYSTEM; LABORATORY DIAGNOSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REDUCTION; REVIEW; SPECTROPHOTOMETRY;

EID: 0037505644     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00200-6     Document Type: Review

References (174)

1. Meister A., Larsson A. Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic basis of inherited disease. 6th ed. 1989;855-868 McGraw-Hill, New York.
2. Chai Y.C., Ashraf S.S., Rokutan K., Johnston R.B. Jr., Thomas J.A. S-thiolation of individual human neutrophil proteins including actin by stimulation of the respiratory burst: evidence against a role for glutathione disulfide. Arch. Biochem. Biophys. 310:1994;273-281.
3. Cotgreave I.A., Gerdes R.G. Recent trends in glutathione biochemistry. Glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun. 242:1998;1-9.
4. Klatt P., Lamas S. Regulation of protein function by S-glutathionylation in response to oxidative and nitrosative stress. Eur. J. Biochem. 267:2000;4928-4944.
5. Fratelli M., Demol H., Puype M.et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. PNAS. 99:2002;3505-3510.
6. Bursell S.E., King G.L. The potential use of glutathionyl hemoglobin as a clinical marker of oxidative stress. Clin. Chem. 46:2000;145-146.
7. Niwa T., Naito C., Mawjood A.H.M.et al. Increased glutathionyl hemoglobin in diabetes mellitus and hyperlipidemia demonstrated by liquid chromatography/electrospray ionization-mass spectrometry. Clin. Chem. 46:2000;82-88.
8. Reed D.J., Fariss M.W. Glutathione depletion and susceptibility. Pharmacol. Rev. 36:1994;235-335.
9. Griffith O.W., Meister A. Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. U. S. A. 82:1985;4668-4672.
10. Martensson J., Lai J.C.K., Meister A. High affinity transport of glutathione is part of a multi-component system essential for mitochondrial function. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7185-7189.
11. Chen Z., Lash L.H. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J. Pharmacol. Exp. Ther. 285:1998;608-618.
12. Meister A. On the enzymology of amino acid transport. Science. 180:1973;33-39.
13. Meister A., Anderson M.E. Glutathione. Ann. Rev. Biochem. 52:1983;711-760.
14. Shi Z.Z., Osei-Frimpong J., Kala G.et al. Glutathione synthesis is essential for mouse development but not for cell growth in culture. PNAS. 97(10):2000;5101-5106.
15. Griffith O.W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-buthyl homocysteine sulfoximine). J. Biol. Chem. 254:1979;7558-7560.
16. Richman P.G., Orlowski M., Meister A. Inhibition of γ-glutamylcysteine synthetases by L-methionine-S-sulfoximine. J. Biol. Chem. 248:1973;6684-6690.
17. Ronzio R., Meister A. Phosphorylation of methionine sulfoximine by glutamine synthetase. Proc. Natl. Acad. Sci. U. S. A. 59:1968;164-170.
18. Griffith O.W., Meister A. Differential inhibition of glutamine and g-glutamylcysteine synthetases by a-alkyl analogs of methionine sulfoximine that induce convulsions. J. Biol. Chem. 253:1978;2333-2338.
19. Wilson H., Cannan R.K. The glutamic acid-pyrrolidonecarboxylic acid system. J. Biol. Chem. 119:1937;309-405.
20. Meister A., Bukenberger M.W. Enzymatic conversion of D-glutamic acid to D-pyrrolidone carboxylic acid by mammalian tissues. Nature. 194:1962;557-561.
21. Meister A., Tate S.S., Ross L.L. Membrane bound γ-glutamyl transpeptidase. Martinosi A. The enzymes of biological membranes. vol. 3:1976;315-347 Plenum, New York.
22. Meister A. Current status of the g-glutamyl cycle. Functions of glutathione in liver and kidney. 1978;43-59 Springer-Verlag, Berlin.
23. Griffith O.W., Meister A. Glutathione: interorgan translocation, turnover and metabolism. Proc. Natl. Acad. Sci. U. S. A. 76:1979;5606-5610.
24. Van der Werf P., Meister A. The metabolic formation and utilization of 5-oxo-L-proline (L-pyroglutamate, L-pyrrolidone carboxylate). Adv. Enzymol. 43:1975;519-556.
25. Van der Werf P., Stephani R.A., Meister A. Accumulation of 5-oxo-L-proline in mouse tissues after inhibition of 5-oxo-L-prolinase and administration of aminoacids: evidence for function of γ-glutamyl cycle. Proc. Natl. Acad. Sci. U. S. A. 71:1974;1026-1029.
26. Sekura R., Meister A. Glutathione turnover in the kidney. Considerations relating to the γ-glutamyl cycle and the transport of aminoacids. Proc. Natl. Acad. Sci. U. S. A. 71:1974;2969-2972.
27. Abbott W.A., Meister A. Modulation of γ-glutamyl transpeptidase activity by bile acids. J. Biol. Chem. 258:1983;6193-6197.
28. Meister A. Novel drugs that affect glutathione metabolism. Mechanisms of drug resistance in neoplastic cells: Part II. Enzymatic basis of drug resistance. 1988;99-126 Academic Press, New York.
29. Williamson J.M., Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. U. S. A. 78:1981;936-939.
30. Williamson J.M., Boettcher B., Meister A. An intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. U. S. A. 79:1982;6246-6249.
31. Anderson M.E., Meister A. Transport and direct utilization of g-glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. U. S. A. 80:1983;707-711.
32. Meister A. Selective modification of glutathione metabolism. Science. 220:1983;471-477.
33. Rossi R., Milzani A., Dalle-Donne I.et al. Blood glutathione disulfide: in vivo factor or in vitro artifact? Clin. Chem. 48:2002;742-753.
34. Srivastava S.K., Beutler E. Accurate measurements of oxidized glutathione content of human, rabbit, and rat red blood cells and tissues. Anal. Biochem. 25:1968;70-76.
35. Pastore A., Piemonte F., Locatelli M.et al. Determination of blood total, reduced and oxidized glutathione in pediatric subjects. Clin. Chem. 47:2001;1467-1469.
36. 1H-MRS. Neurology. 57:2001;1422-1427.
37. Reglinski J., Smith W.E., Brzeski M., Marabani M., Sturock R.D. Clinical analysis by H spin-echo NMR: 2. Oxidation of intracellular glutathione as a consequence of penicillamine therapy in rheumatoid arthritis. J. Med. Chem. 35:1992;2134-2137.
38. Mansoor M.A., Svardal A.M., Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 200:1992;218-229.
39. Mansoor M.A., Svardal A.M., Schneede J., Ueland P.M. Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men. Clin. Chem. 38:1992;1316-1321.
40. Baeyens W., Van der Weken G., Lin Ling B.et al. HPLC determination of N-acetylcysteine in pharmaceutical preparations after pre-column derivatization with Thiolyte®MB using fluorescence detection. Anal. Lett. 21:1988;741-757.
41. Refsum H., Ueland P.M., Svardal A.M. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin. Chem. 35:1989;1921-1927.
42. Jacobsen D.W., Gatautis V.J., Green R. Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection. Anal. Biochem. 178:1989;208-214.
43. Fermo I., Arcelloni C., Devecchi E.et al. High-performance liquid chromatographic method with fluorescence detection for the determination of total homocyst(e)ine in plasma. J. Chromatogr. 593:1992;171-176.
44. Baeyens W., van der Weken G., de Moerloose P. Effects of reducing agents on the determination of thiolic compounds in the presence of their disulfides using bimane pre-column derivatization. Chromatographia. 23:1987;717-721.
45. Han J.C., Han G.Y. A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol. Anal. Biochem. 220:1994;5-10.
46. Anderson M.T., Trudell J.R., Voehringer D.W.et al. An improved monobromobimane assay for glutathione utilizing tris-(2-carboxyethyl)phosphine as the reductant. Anal. Biochem. 272:1999;107-109.
47. Abukhalaf I.K., Silvestrov N.A., Menter J.M.et al. High performance liquid chromatographic assay for the quantitation of total glutathione in plasma. J. Pharm. Biomed. Anal. 28:2002;637-643.
48. Munday R. Toxicity of thiols and disulfides: involvement of free-radical species. Free Radic. Biol. Med. 7:1989;659-673.
49. Yoshida T. Determination of reduced and oxidized glutathione in erythrocytes by high-performance liquid chromatography with ultraviolet absorbance detection. J. Chromatogr., B. 678:1996;157-164.
50. Reeve J., Kuhlenkamp J. Estimation of glutathione in rat liver by reversed-phase high performance liquid chromatography: separation from cysteine and γ-glutamylcysteine. J. Chromatogr. 194:1980;424-428.
51. Reed D.J., Babson J.R., Beatty P.W., Brodie A.E., Ellis W.W., Potter D.W. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal. Biochem. 106:1980;55-62.
52. Russell J., McKeown J.A., Hensman C., Smith W.E., Reglinski J. HPLC determination of biologically active thiols using pre-column derivatization with 5,5′-dithio-(bis-2-nitrobenzoic acid). J. Pharm. Biomed. Anal. 15:1997;1757-1763.
53. Katrusiak A.E., Paterson P.G., Huse K., Shoker A., Lyon A.W. Pre-column derivatization high-performance liquid chromatographic method for determination of cysteine, cysteinyl-glycine, homocysteine and glutathione in plasma and cell extracts. J. Chromatogr., B. 758:2001;207-212.
54. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
55. Ohkura Y., Nohta H. Fluorescence derivatization in high-performance liquid chromatography. Adv. Chromatogr. 29:1989;221-258.
56. Fahey R.C., Newton G.L., Dorian R.et al. Analysis of biological thiols: quantitative determination of thiols at the picomole level based upon derivatization with monobromobimanes and separation by cation-exchange chromatography. Anal. Biochem. 111:1981;357-365.
57. Pastore A., Massoud R., Motti C.et al. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine and 2-mercaptopropionylglycine in plasma and urine. Clin. Chem. 44:1998;825-832.
58. Svardal A.M., Mansoor M.A., Ueland P.M. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with pre-column derivatization with monobromobimane and liquid chromatography. Anal. Biochem. 184:1990;338-346.
59. Imai K., Uzu S., Toyo'oka T. Fluorogenic reagents, having benzofurazan structure, in liquid chromatography. J. Pharm. Biomed. Anal. 7:1989;1395-1403.
60. Toyo'oka T., Imai K. High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium-7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F). J. Chromatogr. 282:1983;495-500.
61. Oe T., Ohyagi T., Naganuma A. Determination of γ-glutamylglutathione and other low-molecular-mass biological thiol compounds by isocratic high-performance liquid chromatography with fluorometric detection. J. Chromatogr., B. 708:1998;285-289.
62. Paroni R., De Vecchi E., Cighetti G.et al. HPLC with o-phthalaldehyde precolumn derivatization to measure total, oxidized, and protein-bound glutathione in blood, plasma, and tissue. Clin. Chem. 41:1995;448-454.
63. Cereser C., Guichard J., Drai J.et al. Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts. J. Chromatogr., B. 752:2001;123-132.
64. Owens C.W.I., Belcher R.V. A colorimetric micro-method for the determination of glutathione. Biochem. J. 94:1965;705-711.
65. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
66. Cohn V.H., Lyle J. A fluorometric assay for glutathione. Anal. Biochem. 14:1966;434-440.
67. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226.
68. Romero F.J., Mueller-Klieser W. Semiquantitative bioluminescent assay of glutathione. J. Biolumin. Chemilumin. 13:1998;263-266.
69. Piccoli G., Fiorani M., Biagiarelli B.et al. Simultaneous high-performance capillary electrophoretic determination of reduced and oxidized glutathione in red blood cells in the femtomole range. J. Chromatogr., A. 676:1994;239-246.
70. Jin W., Li W., Xu Q. Quantitative determination of glutathione in single human erythrocytes by capillary zone electrophoresis with electrochemical detection. Electrophoresis. 21:2000;774-779.
71. Carru C., Zinellu A., Mario Pes G.et al. Ultrarapid capillary electrophoresis method for the determination of reduced and oxidized glutathione in red blood cells. Electrophoresis. 23:2002;1716-1721.
72. Rabenstein D.L., Saetre R. Mercury-based electrochemical detector of liquid chromatography for the detection of glutathione and other sulfur-containing compounds. Anal. Chem. 49:1977;1036-1039.
73. Allison L.A., Mayer G.S., Shoup R.E. o-Phthalaldehyde derivatives of amines for high-speed liquid chromatography/electrochemistry. Anal. Chem. 56:1984;1089-1096.
74. Richie J.P. Jr., Lang C.A. The determination of glutathione, cyst(e)ine and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal. Biochem. 163:1987;9-15.
75. Hiraku Y., Murata M., Kawanishi S. Determination of intacellular glutathione and thiols by high performance liquid chromatography with a gold electrode at the femtomole level: comparison with a spectroscopic assay. Biochim. Biophys. Acta. 1570:2002;47-52.
76. Harvey P.R., Ilson R.G., Strasberg S.M. The simultaneous determination of oxidized and reduced glutathiones in liver tissue by ion pairing reverse phase high performance liquid chromatography with a coulometric electrochemical detector. Clin. Chim. Acta. 180:1989;203-212.
77. Rose R.C., Bode A.M. Analysis of water-soluble antioxidants by high-pressure liquid chromatography. Biochem. J. 306:1995;101-105.
78. Imai K., Toyo'oka T., Watanabe Y. A novel fluorogenic reagent for thiols: ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate. Anal. Biochem. 128:1983;471-473.
79. Fiskerstrand T., Refsum H., Kvalheim G., Ueland P.M. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin. Chem. 39:1993;263-271.
80. Capitan P., Malmezat T., Breuillè D., Obled C. Gas chromatographic-mass spectrometric analysis of stable isotopes of cysteine and glutathione in biological samples. J. Chromatogr., B. 732:1999;127-135.
81. Tsikas D., Raida M., Sandman J., Rossa S., Forssmann W.G., Frolich J.C. Electrospray ionization mass spectrometry of low-molecular-mass S-nitroso compounds and their thiols. J. Chromatogr., B. 742:2000;99-108.
82. Camera E., Rinaldi M., Briganti S., Picardo M., Fanali S. Simultaneous determination of reduced and oxidized glutathione in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry. J. Chromatogr., B. 757:2001;69-78.
83. Norris R.L., Eaglesham G.K., Shaw G.R.et al. A sensitive and specific assay for glutathione with potential application to glutathione disulphide, using high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr., B. 762:2001;17-23.
84. Trabesinger A.H., Weber O.M., Duc C.O., Boesiger P. Detection of glutathione in the human brain in vivo by means of double quantum coherence. Magn. Reson. Med. 42:1999;283-289.
85. Trabesinger A.H., Boesiger P. Improved selectivity of double quantum coherence filtering for the detection of glutathione in the human brain in vivo. Magn. Reson. Med. 45:2001;708-710.
86. Al-Turk W.A., Stohs S.J., El-Rashidy F.H.et al. Changes in glutathione and its metabolizing enzymes in human erythrocytes and lymphocytes with age. J. Pharm. Pharmacol. 39:1987;13-16.
87. Matsubara L.S., Machado P.E. Age-related changes of glutathione content, glutathione reductase and glutathione peroxidase activity of human erythrocytes. Braz. J. Med. Biol. Res. 24:1991;449-454.
88. Lang C.A., Naryshkin S., Schneider D.L., Mills B.J., Lindeman R.D. Low blood glutathione concentrations in healthy aging adults. J. Lab. Clin. Med. 120:1992;720-725.
89. Mills B.J., Richie J.P. Jr., Lang C.A. Glutathione disulfide variability in normal human blood. Anal. Biochem. 222:1994;95-101.
90. Michelet F., Gueguen R., Leroy P.et al. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin. Chem. 41:1995;1509-1517.
91. Richie J.P. Jr., Skowronski L., Abraham P.et al. Blood glutathione concentrations in a large-scale human study. Clin. Chem. 42:1996;64-70.
92. Ono H., Sakamoto A., Satura N. Plasma total glutathione concentrations in healthy pediatric and adult subjects. Clin. Chim. Acta. 312:2001;227-229.
93. Gambhir J.K., Lali P., Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin. Biochem. 30:1997;351-352.
94. Pirmohamed M., Williams D., Tingle M.D.et al. Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS. 10:1996;501-507.
95. Samiec P.S., Drews-Botsch C., Flagg E.W.et al. Glutathione in human plasma: decline in association with ageing, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 24:1998;699-704.
96. Degl'Innocenti D., Rosati F., Iantomasi T.et al. GSH system in relation to redox state in dystrophic skin fibroblasts. Biochimie. 81:1999;1025-1029.
97. Bonnefont-Rousselot D., Lacomblez L., Jaudon M.et al. Blood oxidative stress in amyotrophic lateral sclerosis. J. Neurol. Sci. 178:2000;57-62.
98. Cecchi C., Latorraca S., Sorbi S.et al. Glutathione level is altered in lymphoblasts from patients with familial Alzheimer's disease. Neurosci. Lett. 275:1999;152-154.
99. Hadi Y.M., Kacmaz M., Serda Ozturk H.et al. Antioxidant status of erythrocytes from patients with cirrhosis. Hepato-Gastroenterol. 46:1999;2460-2463.
100. Lou M.F., Dickerson J.E. Protein-thiol mixed disulfides in human lens. Exp. Eye Res. 55:1992;889-896.
101. Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 16:2000;534-554.
102. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31:1999;273-300.
103. Xia C., Hu J., Ketterer B., Taylor J.B. The organization of the human GSTP 1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 313:1996;155-161.
104. Adler V., Yin Z., Fuchs S.Y.et al. Regulation of JNK signaling by GSTp. EMBO J. 18:1999;1321-1334.
105. Klatt P., Lamas S. Regulation of protein function by S-glutathionylation in response to oxidative and nitrosative stress. Eur. J. Biochem. 267:2000;4928-4944.
106. Ravichandran V., Seres T., Moriguchi T., Thomas J.A., Johnston R.B. S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J. Biol. Chem. 269:1994;25010-25015.
107. Schuppe-Koisinen I., Moldeus P., Bergmann T., Coatgreave I.A. S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur. J. Biochem. 221:1994;1033-1037.
108. Klatt P., Molina E.S., Lacoba M.C.et al. Redox regulation of c-Jun DNA binding by reversible S-glutathionylation. FASEB J. 13:1999;1481-1490.
109. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:1992;128-130.
110. Barrett W.C., DeGnore J.P., Keng Y.F., Zhang Z.Y., Yim M.B., Chock P.B. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatease 1B. J. Biol. Chem. 274:1999;34543-34546.
111. Rokutan K., Johnson R.B., Kaway K. Oxidative stress induces S-thiolation of specific proteins in cultured gastric mucosal cells. Am. J. Physiol. 266:1994;G247-G254.
112. Wang J., Boja E.S., Tan W.et al. Reversible glutathionylation regulates actin polymerization in A431 cells. J. Biol. Chem. 276:2001;47763-47766.
113. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16:1996;2553-2562.
114. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62:2000;649-671.
115. Kannan R., Mittur A., Bao Y.et al. GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter. J. Neurochem. 73:1999;390-399.
116. Li X., Wallin C., Weber S.G.et al. Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation dependence on γ-glutamyl transpeptidase. Brain Res. 815:1999;81-88.
117. Schulz J.B., Lindenau J., Seyfried J.et al. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267:2000;4904-4911.
118. Anderson M.E. Glutathione and glutathione delivery compounds. Adv. Pharmacol. 38:1997;65-78.
119. Altomare E., Vendemiale G., Alano O. Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. Life Sci. 43:1998;991-998.
120. Sen C.K. Nutritional biochemistry of cellular glutathione. Nutr. Biochem. 8:1997;660-672.
121. Loguercio C., Taranto D., Vitale L.M.et al. Effect of liver cirrhosis and age on the glutathione concentration in plasma, erythrocytes, and gastric mucosa of man. Free Radic. Biol. Med. 20:1996;483-488.
122. Iantomasi T., Marraccini P., Favilli F.et al. Glutathione metabolism in Crohn's disease. Biochem. Med. Metab. Biol. 53:1994;87-91.
123. Amano J., Suzuki A., Sunamori M. Salutary effect of reduced glutathione on renal function in coronary artery bypass operation. J. Am. Coll. Surg. 179:1994;714-720.
124. Kugiyama K., Ohgushi M., Motoyama T.et al. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation. Circulation. 97:1998;2299-2301.
125. Kidd P.M. Glutathione: systemic protectant against oxidative and free radical damage. Altern. Med. Rev. 1:1997;155-176.
126. Gut A., Chaloner C., Schofield D.et al. Evidence of toxic metabolite stress in black South Africans with chronic pancreatitis. Clin. Chim. Acta. 236:1995;145-153.
127. Yoshida K., Hirokawa J., Tagami S.et al. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia. 38:1995;201-210.
128. Hengstler J.G., Arand M., Herrero M.E.et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res. 154:1998;47-85.
129. Sun G.F., Shimojo N., Pi J.B., Lee S., Kumagai Y. Gene deficiency of glutathione S-transferase mu: isoform associated with susceptibility to lung cancer in a Chinese population. Cancer Lett. 113:1997;169-172.
130. Harrison D.J., Cantlay A.M., Rae F., Lamb D., Smith C.A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Human Exp. Toxicol. 16:1997;356-360.
131. Garcia-Closas M., Kelsey K.T., Wiencke J.K., Xu X., Wain J.C., Christiani D.C. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility. Cancer Causes Control. 8:1997;544-553.
132. Paolisso G., Tagliamonte M.R., Rizzo M.R.et al. Oxidative stress and advancing aging: results in healthy centenarians. J. Am. Geriatr. Soc. 46:1998;833-838.
133. Weber G.F., Mirza N.M., Yunis E.J.et al. Localization and treatment of an oxidation-sensitive defect within the TCR-coupled signalling pathway that is associated with normal and premature immunologic aging. Growth Dev. Aging. 61:1997;191-207.
134. Banaclocha M.M., Hernandez A.I., Martinez N.et al. N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria. Brain Res. 762:1997;256-258.
135. Gabby M., Tauber M., Porat S., Simantov R. Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis. Neuropharmacology. 35(5):1996 (May);571-578.
136. Dogru-Abbasoglu S., Tamer-Toptani S., Ugurnal B.et al. Lipid peroxidation and antioxidant enzymes in livers and brains of aged rats. Mech. Ageing Dev. 98:1997;177-180.
137. Garcia-Arumi E., Andreu A.L., Lopez-Hellin J.et al. Effect of oxidative stress on lymphocytes from elderly subjects. Clin. Sci. 94:1998;447-452.
138. Droge W., Pottmeyer-Gerber C., Schmidt H.et al. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology. 172:1986;151-156.
139. Gmunder H., Droge W. Differential effects of glutathione depletion on T cell subsets. Cell. Immunol. 138:1991;229-237.
140. Staal F.J.T., Roederer M., Herzenberg L.A.et al. Intracellular thiols regulate activation of nuclear factor kB and transcription of immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 87:1990;9943-9947.
141. Mihm S., Galter D., Droge W. Modulation of transcription factor NF-kB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J. 9:1995;246-252.
142. Tewes F., Bol G.F., Brigelius-Flohe R. Thiol modulation inhibits the interleukin-1-mediated activation of an IL-1 receptor associated protein kinase and NF-kB. Eur. J. Immunol. 27:1997;3015-3021.
143. Weber G.F., Mirza N.M., Yunis E.J.et al. Localization and treatment of an oxidation-sensitive defect within the TCR coupled signalling pathway that is associated with normal and premature immunologic aging. Growth Dev. Aging. 61:1997;191-207.
144. Witsch A., Reddy S., Stofer B.et al. The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol. 43:1992;667-669.
145. Hagen T.M., Wierzbicka G.T., Sillau A.H.et al. Bioavailability of dietary glutathione: effect on plasma concentrations. Am. J. Physiol. 259:1990;G524-G529.
146. Vincenzini M.T., Favilli F., Iantomasi T. Intestinal uptake and transmembrane transport system of intact GSH; characteristics and possible biological role. Biochim. Biophys. Acta. 1113:1992;13-23.
147. Gohil K., Viguie C., Stanley W.C.et al. Blood glutathione oxidation during human exercise. Jpn. J. Appl. Phys. 64:1988;115-119.
148. Kilinc A., Yalcin A.S., Yalcin D.et al. Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease. Neurosci. Lett. 87:1998;307-310.
149. Stahlberg M.R., Hietaen E. Glutathione and glutathione-metaboling enzymes in the erythrocytes of healthy children and in children with insulin-dependent diabetes mellitus, juvenile rheumatoid arthritis, celiac disease and acute lymphoblastic leukaemia. Scand. J. Clin. Lab. Invest. 5:1990;125-130.
150. Toth K.M., Berger E.M., Beehler C.J.et al. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am. Rev. Respir. Dis. 134:1986;281-284.
151. Adams J.D., Johannesen J.N., Bacon J.P. Quantification of glutathione and glutathione disulfide in human plasma. Clin. Chem. 33:1987;1675-1676.
152. Adams J.D., Khaw E., Jaresko G.et al. Plasma glutathione and glutathione disulfide in alcoholics during detoxification. Res. Commun. Subst. Abuse. 11:1990;153-165.
153. Beutler E., Gelbart T. Plasma glutathione in health and in patients with malignant disease. J. Lab. Clin. Med. 105:1985;581-584.
154. Flagg E.W., Coates R.J., Jones D.P.et al. Plasma total glutathione in humans and its association with demographic and health-related factors. Br. J. Nutr. 70:1993;797-808.
155. Kretzschmar M., Muller D., Hubscher J.et al. Influence of aging, training and acute physical excercise on plasma glutathione and lipid peroxides in man. Int. J. Sports Med. 12:1991;218-222.
156. Paolisso G., Di Maro G., Pizza G.et al. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am. J. Physiol. 263:1992;E435-E440.
157. Shigesawa T., Sato C., Marumo F. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease. J. Gastroenterol. Hepatol. 7:1992;7-11.
158. Hercbergs A., Brok-Simoni F., Holtzman F., Bar-Am J., Leith J.T., Brenner H.J. Erythrocyte glutathione and tumor response to chemotherapy. Lancet. 339:1992;1074-1076.
159. Jacobson S.H., Moldeus P. Whole blood, plasma and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis. Clin. Nephrol. 42:1994;189-192.
160. Golik A., Weissgarten J., Evans S.et al. Changes in red blood cell glutathione and glutathione-dependent enzymes on long-term treatment with captopril and enalapril. Clin. Chim. Acta. 240:1995;89-94.
161. Delmas-Beauvieux M.C., Peuchant E., Couchoron A.et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or b-carotene. Am. J. Clin. Nutr. 64:1996;101-107.
162. Rybczynska M., Pawlak A.L., Sikorska E., Ignatowicz R. Ataxia telangiectasia heterozygotes and patients display increased fluidity and decrease in contents of sulfhydryl groups in red blood cell membranes. Biochim. Biophys. Acta. 1302:1996;231-235.
163. Herzenberg L.A., De Rosa S.C., Dubs J.G.et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1967-1972.
164. Navarro J., Obrador E., Pellicer J.A., Asensi M., Vina J., Estrela J.M. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic. Biol. Med. 22:1997;1203-1209.
165. Samiec P.S., Drews-Botsch C., Flagg E.W.et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 24:1998;699-704.
166. Spickett C.M., Reglinski J., Smith W.E., Wilson R., Walker J.J., McKillop J. Erythrocyte glutathione balance and membrane stability during preeclampsia. Free Radic. Biol. Med. 24:1998;1049-1055.
167. Baron V., Muriel P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstrution in the rat. Biochim. Biophys. Acta. 1472:1999;173-180.
168. Jahoor F., Jackson A., Gazzard B.et al. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. Am. J. Physiol. 276:1999;E205-E211.
169. Navarro J., Obrador E., Carretero J.et al. Changes in glutathione status and antioxidant system in blood and in cancer cells associate with tumor growth in vivo. Free Radic. Biol. Med. 26:1999;410-418.
170. Pantke U., Volk T., Smutzler M., Kox W.J., Sitte N., Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic. Biol. Med. 27:1999;1080-1086.
171. Papp A., Nemeth I., Karg E., Papp E. Glutathione status in retinopathy of prematurity. Free Radic. Biol. Med. 27:1999;738-743.
172. Kharb S. Low whole blood glutathione levels in pregnancies complicated by preeclampsia and diabetes. Clin. Chim. Acta. 294:2000;179-183.
173. Lang C.A., Mills B.J., Mastropaolo W., Liu M.C. Blood glutathione decreases in chronic diseases. J. Lab. Clin. Med. 135:2000;402-405.
174. Mills B.J., Weiss M.M., Lang C.A., Liu M.C., Ziegler C. Blood glutathione and cysteine changes in cardiovascular disease. J. Lab. Clin. Med. 135:2000;396-402.